Literature DB >> 6708205

Biological effects of hormonal treatment regimens on a transplantable human prostatic tumor line (PC-82).

G J van Steenbrugge, M Groen, J C Romijn, F H Schröder.   

Abstract

The effects of hormonal manipulation on the growth of a transplantable human prostatic carcinoma line (PC-82) were studied. The histological pattern of the PC-82 tumor, which still closely resembles the original tumor material, and the tumor growth rate did not change during the subsequent mouse passages. Growth of PC-82 tumor tissue on female and castrated male mice did not occur. Castration of tumor-bearing mice resulted in a cessation of tumor growth, after which the tumor volume decreased 50 +/- 27 per cent within 6 weeks after castration. Hormone-independent regrowth of the tumor tissue was not observed after long-term withdrawal of androgens. After a period of 10 weeks following tumor growth arrest, administration of testosterone almost directly resulted in regrowth of the tumor. Hormones, testosterone and estradiol, were administered by silastic implants. Intact male nude mice were shown to have highly fluctuating levels of testosterone. Implantation with testosterone resulted in constant levels of circulating testosterone, which could be maintained for at least 10 weeks, while the mean concentration of plasma testosterone was not different from that in control male mice. The doubling time of tumors grown on testosterone-substituted intact female and intact and castrated male mice was significantly shorter than that of tumors grown on intact male mice. Histologically the tumors grown on androgen-substituted mice were similar to those grown on untreated mice; the mitotic index, however, was much higher in the testosterone treated animals. Implantation of intact male mice with estradiol suppressed plasma testosterone to a mean level of 1 ng. per ml. and prevented the growth of PC-82 tumor tissue almost completely. Treatment of tumor-bearing mice with an estradiol implant following androgen withdrawal did not result in a further decrease of the tumor volume compared to the mice without additional estradiol implantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708205     DOI: 10.1016/s0022-5347(17)50630-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Development of seven new human prostate tumor xenograft models and their histopathological characterization.

Authors:  W M van Weerden; C M de Ridder; C L Verdaasdonk; J C Romijn; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

2.  Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.

Authors:  W M van Weerden; A van Kreuningen; E P Moerings; F H de Jong; G J van Steenbrugge; F H Schröder
Journal:  Urol Res       Date:  1991

3.  Metastatic potential of human renal cell carcinoma: experimental model using subrenal capsule implantation in athymic nude mice.

Authors:  F S Grossi; X Zhao; J C Romijn; F J ten Kate; F H Schröder
Journal:  Urol Res       Date:  1992

Review 4.  Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer.

Authors:  N Kyprianou
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

5.  Establishing prostate cancer patient derived xenografts: lessons learned from older studies.

Authors:  Pamela J Russell; Peter Russell; Christina Rudduck; Brian W C Tse; Elizabeth D Williams; Derek Raghavan
Journal:  Prostate       Date:  2015-01-05       Impact factor: 4.104

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.